How to improve loco-regional control in stages IIIa–b NSCLC?: Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group
- 31 July 2009
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 65 (1) , 62-67
- https://doi.org/10.1016/j.lungcan.2008.10.021
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trialLung Cancer, 2007
- PD5-2-7: Hiperfractionated (HFRT) versus Standard Radiotherapy (SRT) in Locally Advanced (LA) NSCLC: a metaanalysis of randomized phase III trialsJournal of Thoracic Oncology, 2007
- A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancerAnti-Cancer Drugs, 2007
- Simultaneous Chemoradiotherapy Compared With Radiotherapy Alone After Induction Chemotherapy in Inoperable Stage IIIA or IIIB Non–Small-Cell Lung Cancer: Study CTRT99/97 by the Bronchial Carcinoma Therapy GroupJournal of Clinical Oncology, 2006
- Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non???Small Cell Lung CancerJournal of Thoracic Oncology, 2006
- Combined chemotherapy and radiation in locally advanced nonsmall-cell lung cancerThe Lancet Oncology, 2001
- Paclitaxel as a radiosensitiser: A proposed schedule of administration based on in vitro data and pharmacokinetic calculationsEuropean Journal Of Cancer, 1997
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Cranial irradiation in cancer of the lung of all cell typesJAMA, 1981